REVIEW Ponazuril is a triazinedione drug approved for the treatment of equine protozoal myeloencephalitis caused by Sarcocystis neurona. It has also been used in smaller animals against coccidia.
REFERENCES
[1]
Ponazuril is a triazinedione drug currently approved for the treatment of equine protozoal myeloencephalitis caused by Sarcocystis neurona. More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite.
[2]
Kennedy, Thomas J. Triazineone compounds for treating diseases due to Sarcosystis, Neospora and Toxoplasma PCT Int. Appl. (2000), WO 2000037063 A2 20000629.
[3]
Gottstein B, Eperon S, Dai WJ, Cannas A, Hemphill A, Greif G. Efficacy of toltrazuril and ponazuril against experimental Neospora caninum infection in mice. Parasitol Res. 2001 Jan;87(1):43-8.
[4]
Kritzner S, Sager H, Blum J, Krebber R, Greif G, Gottstein B.An explorative study to assess the efficacy of toltrazuril-sulfone (ponazuril) in calves experimentally infected with Neospora caninum. Ann Clin Microbiol Antimicrob. 2002 Oct 18;1:4.
All products are stocked and shipped from San Francisco Bay Area, California, USA.
⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.
Add to Favorites 
Delete from Favorites 
